Protein Expression Systems Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Protein Expression Systems Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Protein expression is an integral tool in biological research and it is gaining significant traction as a pharmaceutical production mechanism for biological therapeutics. The biotechnology industry uses both cell types prokaryotic (bacteria) and eukaryotic (animal, fungi, and plant) to synthesize recombinant proteins. The choice of the host cell depends on the protein expressed. The demand for recombinant proteins has increased as more applications in several fields are commercially available. Recombinant proteins have been utilized as tools for cellular and molecular biology.
Market Dynamics
The demand for protein therapeutics has increased considerably, owing to increase in prevalence of chronic diseases and development of plasma-derived therapies. In recent years, proteins expression systems have gained significant traction for therapeutic applications and the number of proteins launched or approved into clinical trials has continually increased. According to the National Center for Biotechnology Information (NCBI) data of 2021, the U.S. Food and Drug Administration (FDA) approved more than 140 recombinant therapeutic proteins for human use and several hundred are currently in development.
However, high cost associated with therapeutic proteins and stringent government regulations towards approval of protein therapies are expected to hinder market growth. For instance, in India, a vial of Avastin (Bevacizumab mostly produced by the mammalian cell expression system), a monoclonal antibody, cost between US$ 372.65 to US$ 402.46. Moreover, immunogenicity is also a major concern for all recombinant drugs, as all biotechnologically produced therapeutics may exhibit some form of immunogenicity.
Key features of the study:
This report provides in-depth analysis of the protein expression systems market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global protein expression systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Agilent Technologies, Inc., Becton, Dickinson & Company, Lonza Group Ltd., GenScript Biotech Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Takara Bio Inc., Synthetic Genomics Inc., Lucigen Corporation, Promega Corporation, ARTES Biotechnology GmbH, ProteoGenix, Addgene Inc., Geneva Biotech, Profacgen, and Peak Proteins Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global protein expression systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for protein expression systems market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Protein Expression Systems Market, By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
Global Protein Expression Systems Market, By Product Type:
Competent Cells
Instruments
Reagents
Others
Global Protein Expression Systems Market, By Application:
Protein Therapeutics
Research Studies
Global Protein Expression Systems Market, By Region:
North America
By Country:
U.S.
Canada
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Africa
By Country:
South Africa
Central Africa
North Africa
By Expression System:
Mammalian Expression Systems
Insect Expression Systems
Bacterial Expression Systems
Plant Expression Systems
Yeast Expression Systems
Cell Free Expression Systems
By Product Type:
Competent Cells
Instruments
Reagents
Others
By Application:
Protein Therapeutics
Research Studies
Company Profiles
Agilent Technologies, Inc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Becton, Dickinson & Company
Lonza Group Ltd.
GenScript Biotech Corporation
Bio-Rad Laboratories, Inc.
Merck KGaA
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Takara Bio Inc.
Synthetic Genomics Inc.
Lucigen Corporation
“*” marked represents similar segmentation in other categories in the respective section.